- Home
- OPTN vs PMVP Comparison
OPTN vs PMVP Comparison
Compare OPTN & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTN
- PMVP
- Stock Information
- Founded
- OPTN 2010
- PMVP 2013
- Country
- OPTN United States
- PMVP United States
- Employees
- OPTN N/A
- PMVP N/A
- Industry
- OPTN Biotechnology: Pharmaceutical Preparations
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- OPTN Health Care
- PMVP Health Care
- Exchange
- OPTN Nasdaq
- PMVP Nasdaq
- Market Cap
- OPTN 78.4M
- PMVP 85.5M
- IPO Year
- OPTN 2017
- PMVP 2020
- Fundamental
- Price
- OPTN $6.38
- PMVP $1.37
- Analyst Decision
- OPTN Strong Buy
- PMVP Strong Buy
- Analyst Count
- OPTN 3
- PMVP 3
- Target Price
- OPTN $16.67
- PMVP $5.33
- AVG Volume (30 Days)
- OPTN 60.7K
- PMVP 175.1K
- Earning Date
- OPTN 03-06-2025
- PMVP 02-27-2025
- Dividend Yield
- OPTN N/A
- PMVP N/A
- EPS Growth
- OPTN N/A
- PMVP N/A
- EPS
- OPTN N/A
- PMVP N/A
- Revenue
- OPTN $75,672,000.00
- PMVP N/A
- Revenue This Year
- OPTN $13.42
- PMVP N/A
- Revenue Next Year
- OPTN $38.54
- PMVP N/A
- P/E Ratio
- OPTN N/A
- PMVP N/A
- Revenue Growth
- OPTN 5.13
- PMVP N/A
- 52 Week Low
- OPTN $4.82
- PMVP $1.32
- 52 Week High
- OPTN $31.50
- PMVP $2.26
- Technical
- Relative Strength Index (RSI)
- OPTN 49.78
- PMVP 33.56
- Support Level
- OPTN $5.16
- PMVP $1.32
- Resistance Level
- OPTN $6.97
- PMVP $1.50
- Average True Range (ATR)
- OPTN 0.66
- PMVP 0.07
- MACD
- OPTN 0.10
- PMVP -0.01
- Stochastic Oscillator
- OPTN 71.08
- PMVP 16.61
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.